Literature DB >> 19137424

Hyperphosphorylation and accumulation of neurofilament proteins in transgenic mice with Alzheimer presenilin 1 mutation.

Xifei Yang1, Ying Yang, Yougen Luo, Geng Li, Jianzhi Wang, Edward S Yang.   

Abstract

Neurofilaments (NFs) are hyperphosphorylated and accumulate in Alzheimer's disease (AD) brains. In this study, employing the transgenic mouse model, we explored the effect of presenilin 1 (PS-1) mutation on the phosphorylation and distribution of NFs. Western blot analysis showed that there was a significant increase in the phosphorylation of NF-H and NF-M subunits with a concomitant increase in phosphorylated c-Jun N-terminal protein kinase 1/2 (JNK1/2) mitogen-activated protein kinase (MAPK) in hippocampus of PS-1 transgenic mice compared to that of wild-type littermates. Immunohistochemical analysis revealed that phosphorylated NFs accumulated throughout the hippocampal neurons of the transgenic mice. These findings suggest that PS-1 mutation may induce hyperphosphorylation and accumulation of NFs via a JNK1/2-involved mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19137424     DOI: 10.1007/s10571-008-9341-7

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  25 in total

1.  Regulation of neurofilament axonal transport by phosphorylation in optic axons in situ.

Authors:  C Jung; T B Shea
Journal:  Cell Motil Cytoskeleton       Date:  1999

2.  Formation of tau inclusions in knock-in mice with familial Alzheimer disease (FAD) mutation of presenilin 1 (PS1).

Authors:  Kentaro Tanemura; Du-Hua Chui; Tetsuya Fukuda; Miyuki Murayama; Jung-Mi Park; Takumi Akagi; Yoshitaka Tatebayashi; Tomohiro Miyasaka; Tetsuya Kimura; Tsutomu Hashikawa; Yuka Nakano; Takashi Kudo; Masatoshi Takeda; Akihiko Takashima
Journal:  J Biol Chem       Date:  2005-12-23       Impact factor: 5.157

3.  Characterization of a shared epitope in cortical Lewy body fibrils and Alzheimer paired helical filaments.

Authors:  M S Pollanen; C Bergeron; L Weyer
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 4.  The slow axonal transport of cytoskeletal proteins.

Authors:  R A Nixon
Journal:  Curr Opin Cell Biol       Date:  1998-02       Impact factor: 8.382

5.  Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation.

Authors:  G Pigino; A Pelsman; H Mori; J Busciglio
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

6.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Authors:  I Grundke-Iqbal; K Iqbal; Y C Tung; M Quinlan; H M Wisniewski; L I Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 7.  MAPKs: new targets for neurodegeneration.

Authors:  Sarah J Harper; Neil Wilkie
Journal:  Expert Opin Ther Targets       Date:  2003-04       Impact factor: 6.902

8.  Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235.

Authors:  X G Huang; B K Yee; S Nag; S T H Chan; F Tang
Journal:  Exp Neurol       Date:  2003-10       Impact factor: 5.330

9.  Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis.

Authors:  V Manetto; N H Sternberger; G Perry; L A Sternberger; P Gambetti
Journal:  J Neuropathol Exp Neurol       Date:  1988-11       Impact factor: 3.685

10.  Neurofilament phosphorylation is modulated by myelination.

Authors:  R Starr; B Attema; G H DeVries; M J Monteiro
Journal:  J Neurosci Res       Date:  1996-05-15       Impact factor: 4.164

View more
  6 in total

1.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

Review 2.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

3.  Neurofilamentopathy in neurodegenerative diseases.

Authors:  Quan Liu; Fang Xie; Abdiel Alvarado-Diaz; Mark A Smith; Paula I Moreira; Xiongwei Zhu; George Perry
Journal:  Open Neurol J       Date:  2011-08-26

4.  Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models.

Authors:  Stanislaw Mitew; Matthew T K Kirkcaldie; Tracey C Dickson; James C Vickers
Journal:  Front Neuroanat       Date:  2013-09-26       Impact factor: 3.856

5.  Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models.

Authors:  Joerg Neddens; Magdalena Daurer; Stefanie Flunkert; Kerstin Beutl; Tina Loeffler; Lauren Walker; Johannes Attems; Birgit Hutter-Paier
Journal:  PLoS One       Date:  2020-07-09       Impact factor: 3.240

6.  Pharmacological c-Jun NH2-Terminal Kinase (JNK) Pathway Inhibition Reduces Severity of Spinal Muscular Atrophy Disease in Mice.

Authors:  Roberta Schellino; Marina Boido; Tiziana Borsello; Alessandro Vercelli
Journal:  Front Mol Neurosci       Date:  2018-09-04       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.